CMS Energy(CMS)
Search documents
Medicare can now cover Eli Lilly's Zepbound for sleep apnea, CMS says
CNBC· 2025-01-08 20:17
An injection pen of Zepbound, Eli Lilly’s weight loss drug, is displayed in New York City on Dec. 11, 2023.Medicare drug plans can now cover Eli Lilly's blockbuster obesity drug Zepbound for obstructive sleep apnea, CNBC confirmed on Wednesday. That opens the door for broader access to Zepbound, which is not currently covered by Medicare and many other insurance plans for weight loss. Demand for the injection has soared over the last year despite its roughly $1,000 price tag before insurance.In a statement ...
CMS Energy's Arm Announces Plans to Upgrade Natural Gas System
ZACKS· 2024-12-19 15:35
CMS Energy Corporation (CMS) recently revealed that its primary subsidiary, Consumer Energy, has introduced a plan to upgrade its natural gas system, which provides gas to more than 1.8 million homes and businesses in Michigan.Details of CMS’ PlanPer the plan, the company will replace up to 10,000 old gas lines and add valves that can be operated remotely to handle emergencies faster. These improvements will make the system safer, more reliable and better for the environment while keeping it affordable for ...
CMS Energy: Continuing On A Steady Path
Seeking Alpha· 2024-12-13 22:18
At Energy Profits in Dividends, we seek to generate a 7%+ income yield by investing in a portfolio of energy stocks while minimizing our risk of principal loss. By subscribing, you will get access to our best ideas earlier than they are released to the general public (and many of them are not released at all) as well as far more in-depth research than we make available to everybody. In addition, all subscribers can read any of my work without a subscription to Seeking Alpha Premium!We do note, however, that ...
CMS Energy Rides on Investments and Expansion of Renewable Portfolio
ZACKS· 2024-12-13 15:33
CMS Energy Corporation (CMS) is making systematic investments to enhance its operations. It is also benefiting from delivering high-quality services to its consumers. The company is expanding its renewable power portfolio while eliminating coal-generating units.However, this Zacks Rank #3 (Hold) company is exposed to unfavorable costs associated with the shutdown of solid waste disposal facilities for coal ash.Factors Acting in Favor of CMS CMS Energy is investing heavily in infrastructure renovations and r ...
CMS Energy Eliminates More Than 72K Outages With Smart Technology
ZACKS· 2024-12-03 17:56
CMS Energy Corporation (CMS) recently revealed that its primary subsidiary, Consumer Energy, has been successful in eliminating 72,000 outages in 2024. The key to this success is the company’s significant investment in smart technology, specifically the use of Automatic Transfer Reclosers (ATRs). These devices have approximately saved more than 350,000 hours of potential power loss for CMS’ customers this year.This effort is part of Consumers Energy’s Reliability Roadmap to improve the grid. The company pla ...
Wix Recognized as the Most Accessible Website Platform CMS and Best SEO Performer
GlobeNewswire News Room· 2024-12-03 14:00
The annual report, based on expert analysis and comprehensive data, recognized Wix as a leader in web accessibility and SEO NEW YORK — Wix.com (NASDAQ: WIX), the leading SaaS website builder platform globally1, earned top recognition in the 2024 Web Almanac report as the Most Accessible Website Platform CMS and Best SEO Performer. These distinctions reflect Wix's commitment to empowering users with tools that prioritize website accessibility and optimize discoverability. This report, produced by the HTT ...
HeartSciences' AI-ECG Algorithms Assigned CMS Medicare and Medicaid Reimbursement
GlobeNewswire News Room· 2024-11-13 14:00
Southlake, TX, Nov. 13, 2024 (GLOBE NEWSWIRE) -- Heart Test Laboratories, Inc. d/b/a HeartSciences (NASDAQ: HSCS; HSCSW) (“HeartSciences” or the “Company”), an artificial intelligence (AI)-powered medical technology company focused on transforming ECGs/EKGs to save lives through earlier detection of heart disease, today announced that the Centers for Medicare & Medicaid Services (CMS) has included AI-ECG technology in the 2025 Hospital Outpatient Prospective Payment System (OPPS) final rule under assignment ...
Limaca's Precision-GI™ Granted CMS Transitional Pass-Through (TPT) Payment
Prnewswire· 2024-11-07 13:00
Precision-GI™ FDA Designated Breakthrough product and FDA cleared semi-automated motorized endoscopic biopsy device entering U.S. market YOKNEAM, Israel, Nov. 7, 2024 /PRNewswire/ -- The Centers for Medicare & Medicaid Services (CMS) has granted transitional pass-through (TPT) payment for Limaca Medical Ltd. ("Limaca")'s Precision-GI™ motorized endoscopic biopsy device. Limaca's endoscopic device is designed to obtain improved biopsy results for patients with suspected gastrointestinal cancers such as pancr ...
CMS Decision And O&P Network Build Out Make Myomo A Buy
Seeking Alpha· 2024-11-05 20:30
Analyst’s Disclosure: I/we have a beneficial long position in the shares of STXS, DCTH either through stock ownership, options, or other derivatives. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking Alpha). I have no business relationship with any company whose stock is mentioned in this article. I could invest in AVITA Medical or Myomo over the next few months, but won't over the next 2 weeks.Seeking Alpha's Disclosure: Past perf ...
Profound Medical Announces TULSA Reimbursement Raised to Urology APC Level 7 Under CMS Outpatient Prospective Payment System (OPPS) Final Rule for CY2025
GlobeNewswire News Room· 2024-11-04 11:55
– TULSA to stand above all other covered prostate disease treatment modalities at Urology Level 7 reimbursement – – First-time CPT® code reimbursement for TULSA to be effective January 1, 2025 – TORONTO, Nov. 04, 2024 (GLOBE NEWSWIRE) -- Profound Medical Corp. (NASDAQ:PROF; TSX:PRN) (“Profound” or the “Company”), a commercial-stage medical device company that develops and markets customizable, incision-free therapies for the ablation of diseased tissue, today announced that U.S. Centers for Medicare and Med ...